- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07399912
Engaging Home-monitored Assessment to Navigate Clinical Decision-making (ENHANCe)
February 2, 2026 updated by: SingHealth Polyclinics
Engaging Home-monitored Assessment to Navigate Clinical Decision-making -The ENHANCe Study
This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The researchers want to find out if the app is easy to use in everyday clinic settings, whether doctors find it helpful and are willing to use it, and if it helps improve care.
The study will involve 16 doctors and 100 patients with high blood pressure, split into two groups at two clinics.
One group will use the ENHANCe app, which can read blood pressure data from different sources-including handwritten notes-and give doctors advice based on that information.
The other group will receive regular care without the app.
Over six months, researchers will collect feedback from doctors through surveys and group discussions at the end of the study.
They'll also track how many people complete the study, how long clinic visits take, whether doctors follow the app's advice, and how well patients' blood pressure is controlled.
The goal is to see if the app can help doctors make faster, better decisions and improve health outcomes for people managing their blood pressure at home.
Study Type
Interventional
Enrollment (Estimated)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Singapore
-
Singapore, Singapore, Singapore, 150167
- SingHealth Polyclinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
For primary care physicians:
- PCPs aged 21 years and above.
- Involved in the clinical management of patients with hypertension in the past six months.
For patients:
- Patients aged 21 years and above
- Documentation of hypertension diagnosis in EMR
- Owns an HBP monitoring device
Exclusion Criteria for patients:
- Documentation of dementia diagnosis in EMR
- Audio or visual impairments
- Hypertensive urgency or emergency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hypertension management using the Clinical Decision Support System
All patients will have access to online educational resources throughout the study.
After recruitment, they will receive a nurse-led education on HBP monitoring.
The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
The PCPs in the intervention group will be briefed on how the ENHANCe app works, and its recommendations.
The ENHANCe app will be installed on designated mobile phones, and research staff will analyse HBP records during visits, documenting the output for PCPs to use.
Based on the app's recommendations, patients will consult with intervention group PCPs 2-3 times throughout the study, with the last follow-up at 6 months.
PCPs will complete a consult checklist after each visit.
FGDs will be conducted with PCPs at the end of the study.
The interviews will be recorded and transcribed for analysis.
|
ENHANCe app is a prototype; it is a smartphone based clinical decision support (CDS) tool to manage patients with hypertension using their home blood pressure.
The app will scan patients' home BP records from paper or mobile phone, and provide a recommendation to the doctor on how to manage their blood pressure.
The patient will not need to use the device during the study period.
However, the recommendation from the ENHANCe app will be available to the doctor to manage your blood pressure during the study period if the patient is in the intervention group.
All patients will have access to online educational resources throughout the study.
After recruitment, they will receive a nurse-led education on HBP monitoring.
The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
|
|
Other: Hypertension management as per usual care without a clinical decision support system
All patients will have access to online educational resources throughout the study.
After recruitment, they will receive a nurse-led education on HBP monitoring.
The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
Control group PCPs will manage patients using HBP records at their discretion, with a final follow-up scheduled at 6 months.
PCPs will complete a consult checklist after each visit.
Research staff will use the ENHANCe app to analyse BP diaries and document outcomes, but control group PCPs will not have access to the app or its results.
|
All patients will have access to online educational resources throughout the study.
After recruitment, they will receive a nurse-led education on HBP monitoring.
The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
Physicians manage patients using HBP records at their discretion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Response rate of participants
Time Frame: 6 months
|
Participants agreeable to participate in the study
|
6 months
|
|
Agreement with the CDSS recommendation among PCPs
Time Frame: 6 months
|
Proportion of PCPs who agree with the CDSS recommendation in the two groups
|
6 months
|
|
Withdrawal rate
Time Frame: 6 months
|
Proportion of participants who withdrew
|
6 months
|
|
Study completion rate
Time Frame: 6 months
|
Proportion of participants who completed the intervention
|
6 months
|
|
Adverse event rates
Time Frame: 6 months
|
Proportion of adverse events reported in the two groups
|
6 months
|
|
Consult duration
Time Frame: 6 months
|
Consult time in the groups
|
6 months
|
|
Ease of home blood pressure record assessment among PCPS
Time Frame: 6 months
|
Ease of home blood pressure record assessment among PCPS in the two arms
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of CDSS recommendation followed by the PCPS
Time Frame: 6 months
|
Proportion of ENHANCe recommendations followed by the PCPs among the two groups
|
6 months
|
|
Blood pressure control status
Time Frame: 6 months
|
Blood pressure control status among patients in the two groups
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
December 28, 2025
First Submitted That Met QC Criteria
February 2, 2026
First Posted (Actual)
February 10, 2026
Study Record Updates
Last Update Posted (Actual)
February 10, 2026
Last Update Submitted That Met QC Criteria
February 2, 2026
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-4269-APP1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension,Essential
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Beijing Anzhen HospitalRecruitingHypertension | Essential (Primary) HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Laboratorios Richmond S.A.C.I.F.Laboratorios Richmond Colombia SASCompletedHigh Blood Pressure (& [Essential Hypertension])Colombia
-
BayerCompletedHypertension, EssentialGermany
-
University of Kansas Medical CenterNational Institute of General Medical Sciences (NIGMS)Not yet recruitingHigh Blood Pressure (& [Essential Hypertension])
-
Orchestra BioMed, IncMedtronicRecruitingHypertension | Hypertension, Systolic | Hypertension, EssentialUnited States, Germany, Belgium, Australia, France, Spain, Italy, Czechia, Netherlands, United Kingdom, Hungary, Switzerland, Poland, New Zealand
Clinical Trials on ENHANCe app
-
University of WashingtonCenters for Disease Control and PreventionRecruitingArthritis | Osteoarthritis | Rheumatoid Arthritis | Fibromyalgia | Gout | Lupus or SLEUnited States
-
University of WashingtonCompletedMultiple Sclerosis | Muscular Dystrophy | Spinal Cord Injury | Post-polio SyndromeUnited States
-
Fenway Community HealthNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedParent-Child Relations | Language Development | LiteracyUnited States
-
Boston University Charles River CampusNot yet recruitingPhysical Activity
-
University of KwaZuluKing's College London; University of Oxford; University of East Anglia; University... and other collaboratorsCompletedDepression | Myocardial Infarction | HIV Infections | Stroke | Hypertension | Diabetes Mellitus | AsthmaSouth Africa
-
University of British ColumbiaUniversity of Utah; University of Virginia; Frank C. Diener FoundationCompleted
-
University of VermontCompleted
-
University of WashingtonActive, not recruiting
-
Louisiana State University Health Sciences Center...CompletedPeriodontitis, AdultUnited States